The research shows how machine learning can use CT radiomic data and patient demographics to predict shoulder arthroplasty outcomes.

The research shows how machine learning can use CT radiomic data and patient demographics to predict shoulder arthroplasty outcomes.


GAINESVILLE, Fla. (Sept. 9, 2024) – Advita, a global medical technology leader, presented new research showcasing the potential of artificial intelligence and radiomic analyses in shoulder arthroplasty, as well as advances around its Active Intelligence® (AI) ecosystem of smart technologies, at the 35th Congress of International Society for Technology in Arthroplasty (ISTA) in Nashville, Tenn.
“Advita’s presentation of its latest AI-driven research exemplifies our commitment to advancing science and clinical knowledge through novel technology and patient-focused analytic techniques,” said Chris Roche, Advita Senior Vice President, Extremities. “Advita has an amazing team of data scientists and research engineers focused on quantitatively analyzing clinical data such as our AdvitaGPS® CT images, alongside our multi-center clinical research data. The application of this research will facilitate development of new clinical decision support tools that will profoundly change how surgeons treat their patients.”
...The application of this research will facilitate development of new clinical decision support tools that will profoundly change how surgeons treat their patients....
The new research demonstrated how machine learning techniques, such as clustering, can aggregate CT image derived radiomic data with patient demographic data to identify clinically relevant muscle classifications that are predictive of clinical outcomes after shoulder arthroplasty. In the first study, deltoid radiomics from CT scans of 1,382 patients were analyzed to identify five distinct deltoid clusters that were associated with both high levels and low levels of motion, before and after shoulder arthroplasty. This technique can be performed on other muscles, as well as bone, to synthesize complex image data in a manner that can be readily interpreted by clinicians through preoperative planning software.
Two other radiomic studies quantified the 3D deltoid morphology and correlated that radiomic data to clinically relevant thresholds for clinical improvement, identifying the specific radiomic measures that are statistically associated with improved outcomes after shoulder arthroplasty. This unique information is useful for the development of future clinical decision support tools.
Additionally, the company highlighted significant developments in knee and ankle surgery technologies, including the easy adoption of the Newton® knee balancing technology and the accuracy of GPS for total ankle arthroplasty.1 These innovations, powered by Advita AI, empower surgeons with data-rich, low-cost solutions that are designed to improve patient outcomes.
For more information about our AI technologies, visit www.AdvitaAI.com.
About Advita
Advita is a global medical technology leader that empowers orthopedic surgeons with innovative implants, surgical instruments and the Active Intelligence® (AI) ecosystem of smart technologies to give patients EXACTLY what they need to regain mobility. Visit advita.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and X.
References
Nancy Walsh
Senior Director, Marketing Communications
nancy.walsh@advita.com
Courtney Adkins
Marketing Communications Director
courtney.adkins@advita.com
Nancy Walsh
VP, Corporate & Marketing Communications
nancy.walsh@advita.com